AF and SD-OCT useful in diagnosis of AIR

Article

Autofluorescence (AF) and spectral domain optical coherence tomography (SD-OCT) can detect structural abnormalities in patients with autoimmune retinopathy (AIR), according to a recent study.

Autofluorescence (AF) and spectral domain optical coherence tomography (SD-OCT) can detect structural abnormalities in patients with autoimmune retinopathy (AIR), according to a recent study.

Dr Prithvi Mruthyunjaya et al., Department of Ophthalmology, Duke Eye Centre, Durham, North Carolina, USA, completed a retrospective, observational case series of 14 eyes of seven patients wit AIR. The team collected colour fundus photographs, fundus AF images and SD-OCT at presentation.

Six patients had a history of cancer and were diagnosed with cancer-associated retinopathy or melanoma-associated retinopathy. Abnormalities, including loss of outer retinal layers, were found in six patients.

One patient presented with cancer-associated retinopathy and progressive loss of retinal structure, which was linked to the formation of a hyper-AF ring.

Based on the results, it was found that fundus AF and SD-OCT can detect structural abnormalities in patients with AIR. The areas of hyper-AF that correspond to loss of outer-retinal structures include the inner segment/outer segment junction, the external limiting membrane and outer nuclear layer.

To read more please visit the British Journal of Ophthalmology.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.